Photos & Videos
Day 1
Welcome & Keynote
Select the name to view specific video
- Roham Zamanian (Stanford)
- Marc Humbert (Paris-Saclay)
- Lloyd B. Minor (Dean, Stanford School of Medicine)
- Keynote: Marissa Mayer (Sunshine)
Session 1: Epidemiology of drug and toxin-induced pulmonary hypertension
Select the name to view specific video
- WSPH and ESC/ERS guidelines: New classification of PH risk factor - Gérald Simonneau (Paris-Saclay)
- Pharmacovigilance: Capturing a rare-disease signal - Qun-Ying Yue (Uppsala Monitoring Centre, UMC)
- Identifying new drugs associated with PAH - Charles Khouri (Grenoble)
Session 2: Anorexigen-induced pulmonary hypertension
Select the name to view specific video
- PAH associated by aminorex fumarate - Meinhard Kneussl (Vienna)
- From fenfluramine to benfluorex - Laurent Savale (Paris-Saclay)
- Clinical Similarities and differences with IPAH - Raquel Lyn (Stanford)
Session 3: Mechanisms of anorexigen-induced pulmonary hypertension
Select the name to view specific video
- Genetic and molecular mechanisms of Meth-APAH - Vinicio DJ Perez (Stanford)
- Genetics of PAH and drug-associated PAH - David Montani (Paris-Saclay)
- Anorexigen associated Pulmonary vascular pathology - Peter Dorfmüller (Geissen)
- Channelopathies and Pulmonary Vascular Disease - Anna Hemnes (Vanderbilt)
Session 4: Amphetamine-induced cardiopulmonary disease
Select the name to view specific video
- Global Epidemic of amphetamine abuse - Steve Shoptaw (UCLA)
- From methamphetamines to prescription stimulants - Roham Zamanian (Stanford)
- Discussion and Summary of the day - Marlene Rabinovitch (Stanford)
Day 2
Session 1: Drug & toxin-induced PH – toxic oil and chemotherapeutic substances
Select the name to view specific video
- Cardio-Oncology – A Review - Irene Lang (Vienna)
- Toxic oil and pathomechanisms - Pilar Escribano-Subias (Madrid)
- Dasatinib-induced PAH and possible roles of other TKI - Olivier Sitbon (Paris-Saclay)
- TKI’s & PAH: data from the bench (benefits and risks) - Christophe Guignabert (Paris-Saclay)
- Predicting Safer TKI’s Through Transcriptomics - Adam Andruska (Stanford)
- Agents inducing PVOD: alkylating agents and solvents - Marc Humbert (Paris-Saclay)
Session 2: Drug and toxin-induced pulmonary hypertension – new observations
Select the name to view specific video
- Pediatrics - Diazoxide and PAH - Rachel Hopper (Stanford)
- Could leflunomide and teriflunomide induce PAH? - Jason Weatherald (Edmonton)
- Chinese herbs & PAH: The Qing Dai / Indirubin data - Yuichi Tamura (Tokyo)
- Interferon and direct-acting antivirals - Harm Bogaard (Netherlands)
- Round Table Discussion - Faculty / UMC / FDA / EMA
- Summary of the meeting, Adjourn - Roham Zamanian (Stanford